DE69732359D1 - Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten - Google Patents

Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten

Info

Publication number
DE69732359D1
DE69732359D1 DE69732359T DE69732359T DE69732359D1 DE 69732359 D1 DE69732359 D1 DE 69732359D1 DE 69732359 T DE69732359 T DE 69732359T DE 69732359 T DE69732359 T DE 69732359T DE 69732359 D1 DE69732359 D1 DE 69732359D1
Authority
DE
Germany
Prior art keywords
oxazepine
dopamine
preparation
receptor antagonists
morpholin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732359T
Other languages
English (en)
Other versions
DE69732359T2 (de
Inventor
Oskar Axelsson
Dan Peters
Jorgen Scheel-Krueger
Nielsen Elsebet Stergaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Application granted granted Critical
Publication of DE69732359D1 publication Critical patent/DE69732359D1/de
Publication of DE69732359T2 publication Critical patent/DE69732359T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DE69732359T 1996-08-23 1997-08-22 Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten Expired - Lifetime DE69732359T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK88396 1996-08-23
DK88396 1996-08-23
PCT/EP1997/004587 WO1998007710A1 (en) 1996-08-23 1997-08-22 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists

Publications (2)

Publication Number Publication Date
DE69732359D1 true DE69732359D1 (de) 2005-03-03
DE69732359T2 DE69732359T2 (de) 2005-06-23

Family

ID=8098601

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732359T Expired - Lifetime DE69732359T2 (de) 1996-08-23 1997-08-22 Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten

Country Status (6)

Country Link
US (2) US6207662B1 (de)
EP (1) EP0920423B1 (de)
AT (1) ATE287878T1 (de)
AU (1) AU4455397A (de)
DE (1) DE69732359T2 (de)
WO (1) WO1998007710A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1293669A (zh) * 1998-02-26 2001-05-02 纽罗根公司 苄基哌嗪基－和苄基哌啶基－乙酮衍生物、其制备方法及其用作多巴胺d 受体拮抗剂的用途
US6084098A (en) 1999-02-26 2000-07-04 Neurogen Corporation Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
GB201108825D0 (en) * 2011-05-25 2011-07-06 Univ Dundee Morpholino compounds, uses and methods
WO2016065576A1 (en) * 2014-10-30 2016-05-06 Tianjin Weijie Pharmaceutical Co., Ltd. Process for preparation of high purity guaiacol glycidyl ether

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1260886A (en) * 1969-06-20 1972-01-19 Ici Ltd Process for aryloxymethylmorpholine derivatives
GB1310236A (en) 1970-05-21 1973-03-14 Ici Ltd Morpholine derivatives
GB1382526A (en) * 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
JPS4982677A (de) * 1972-12-18 1974-08-08
GB1412546A (en) 1973-08-08 1975-11-05 Ici Ltd Morpholine derivatives
GB1427097A (en) 1973-10-18 1976-03-03 Ici Ltd Optically-active morpholine derivatives
GB1436395A (en) 1973-12-13 1976-05-19 Ici Ltd Morpholine derivatives
GB1452701A (en) 1974-05-07 1976-10-13 Ici Ltd Morpholine derivatives
DE2728898A1 (de) 1977-06-27 1979-01-18 Thomae Gmbh Dr K Neue morpholinderivate
JPH01117860A (ja) 1987-10-30 1989-05-10 Dainippon Pharmaceut Co Ltd 安息香酸アミド誘導体
JPH02104572A (ja) 1988-10-13 1990-04-17 Dainippon Pharmaceut Co Ltd 安息香酸アミド誘導体
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
GB9324018D0 (en) 1993-11-23 1994-01-12 Merck Sharp & Dohme Therapeutic agents
GB9411045D0 (en) * 1994-06-02 1994-07-20 Smithkline Beecham Plc Compounds and use

Also Published As

Publication number Publication date
WO1998007710A1 (en) 1998-02-26
US6479491B1 (en) 2002-11-12
AU4455397A (en) 1998-03-06
EP0920423A1 (de) 1999-06-09
DE69732359T2 (de) 2005-06-23
ATE287878T1 (de) 2005-02-15
EP0920423B1 (de) 2005-01-26
US6207662B1 (en) 2001-03-27

Similar Documents

Publication Publication Date Title
ATE226189T1 (de) Saure gruppen enthaltende phenylderivate, ihre herstellung und ihre verwendung als chloridkanalblocker
WO1999042465A3 (en) Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
EE9700283A (et) Bensimidasooli ühendid, nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine
EA200401172A1 (ru) Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии
NO903851D0 (no) Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter.
NZ511584A (en) Benzoxazole substituted piperazine and piperidine derivatives useful for treating central nervous disorders, depression and anxiety
DE69401716D1 (de) Imidazo [1,2-a] pyrasin-4-on-derivate welche als ampa und nmda receptor antagonisten dienen
JO2321B1 (en) 4-phenyl-pyridine derivatives
EE04308B1 (et) Bensimidasooli ühendid, neid ühendeid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine
NZ528997A (en) Sulfonamides
NO964698L (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
PE20050587A1 (es) Derivados de diazindol-dicarbonilo-piperazinilo como agentes antivirales
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
PE20030539A1 (es) Derivados de piperazina antagonistas de los receptores de somatostatina sst1
DE69732359D1 (de) Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten
MXPA05012368A (es) Derivados de amidas del acido 2,3,4,5-tetrahidrobenzo[f] [1,4]oxazepina-5-carboxilico como inhibidores de gamma-secretasa para el tratamiento de la enfermedad de alzheimer.
CA2366205A1 (en) Biphenyl derivatives
NO20012965L (no) Sulfonyloksazolaminer som terapeutisk aktive forbindelser
DE69402935D1 (de) Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
ATE229509T1 (de) Azacyclooktan- und heptan-derivate, ihre herstellung und ihre therapeutische verwendung
HUP0203695A2 (hu) Szubsztituált pirrol Mannichbázisok, előállításuk, alkalmazásuk és ilyent tartalmazó gyógyászati készítmény
DE3769333D1 (de) Acylaminomethylimidazo(1,2-a)pyrimidinderivate, ihre herstellung und therapeutische verwendung.
DE3884319D1 (de) Imidazobenzodiazepine und ihre Säureadditionssalze, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen.
EA200300691A1 (ru) Производные 2,3-бензодиазепина и фармацевтические композиции, содержащие эти производные в качестве активного ингредиента
ATE108444T1 (de) 3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition